郭璠
Lv21
150 积分
2022-12-13 加入
-
Single and Multiple Dose Safety, Pharmacodynamics and Pharmacokinetics of Xanomeline, a Novel Muscarinic M1 Agonist in Healthy Male Subjects
8天前
已完结
-
Investigational melatonin receptor agonists
1个月前
已关闭
-
Efficacy and Safety of Aripiprazole and Haloperidol Versus Placebo in Patients With Schizophrenia and Schizoaffective Disorder
1个月前
已完结
-
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2个月前
已完结
-
The mechanism study of YZG-331 on sedative and hypnotic effects
2个月前
已完结
-
Efficacy and Safety of ES-481, a Novel TARP Inhibitor, in Drug-resistant Epilepsy: A Double-blind Randomized Placebo Controlled Phase IIa Trial (S19.003)
3个月前
已关闭
-
Structure-based design of non-hypertrophic apelin receptor modulator
3个月前
已完结
-
Efficacy and safety of EMA401 in peripheral neuropathic pain: results of 2 randomised, double-blind, phase 2 studies in patients with postherpetic neuralgia and painful diabetic neuropathy
4个月前
已完结
-
Targeting Dopamine and Serotonin Receptors for Psychosis, Mood, and Beyond: So-Called “Antipsychotics”
10个月前
已关闭
-
P534. Initial Assessment of the Clinical Profile of the PDE10A Inhibitor MK-8189 in Patients With an Acute Episode of Schizophrenia
10个月前
已完结